Dong Ran
Director of Finance/CFO bei FENBI LTD.
Profil
Dong Ran is currently an Independent Non-Executive Director at Beijing Biostar Pharmaceuticals Co. Ltd., Chief Financial Officer & Vice President at Fenbi Ltd., and Vice President at Beijing Fenbi Bluesky Technology Co., Ltd.
Previously, he worked as a Director at UBS Securities Hong Kong Ltd.
from 2015 to 2017 and as a Vice President at Macquarie Group from 2017 to 2020.
Mr. Ran received his undergraduate degree from the University of Hong Kong in 2008.
Aktive Positionen von Dong Ran
| Unternehmen | Position | Beginn |
|---|---|---|
| FENBI LTD. | Director of Finance/CFO | 01.09.2020 |
Beijing Fenbi Bluesky Technology Co., Ltd.
 Beijing Fenbi Bluesky Technology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Beijing Fenbi Bluesky Technology Co., Ltd. provides educational and training services. The private company is based in Beijing, China. The Chinese company was founded in 2015 by Yong Li, Changzhen Guo, Xin Li. Xiao Long Zhang has been the CEO of the company since 2015. | Corporate Officer/Principal | 01.11.2020 |
Beijing Biostar Pharmaceuticals Co. Ltd.
 Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | Director/Board Member | 28.12.2023 |
Ehemalige bekannte Positionen von Dong Ran
| Unternehmen | Position | Ende |
|---|---|---|
| Macquarie Group | Corporate Officer/Principal | 01.09.2020 |
UBS Securities Hong Kong Ltd.
 UBS Securities Hong Kong Ltd. Investment Banks/BrokersFinance Part of UBS Group AG, UBS Securities Hong Kong Ltd. is a private company that provides securities brokerage services. The company is based in Hong Kong, Hong Kong. | Director/Board Member | 01.07.2017 |
Ausbildung von Dong Ran
| University of Hong Kong | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| FENBI LTD. | Commercial Services |
| Private Unternehmen | 4 |
|---|---|
UBS Securities Hong Kong Ltd.
UBS Securities Hong Kong Ltd. Investment Banks/BrokersFinance Part of UBS Group AG, UBS Securities Hong Kong Ltd. is a private company that provides securities brokerage services. The company is based in Hong Kong, Hong Kong. | Finance |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | Health Technology |
| Macquarie Group | |
Beijing Fenbi Bluesky Technology Co., Ltd.
Beijing Fenbi Bluesky Technology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Beijing Fenbi Bluesky Technology Co., Ltd. provides educational and training services. The private company is based in Beijing, China. The Chinese company was founded in 2015 by Yong Li, Changzhen Guo, Xin Li. Xiao Long Zhang has been the CEO of the company since 2015. | Commercial Services |
